Jennison Associates LLC Novo Nordisk A S Transaction History
Jennison Associates LLC
- $162 Billion
- Q4 2024
A detailed history of Jennison Associates LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Jennison Associates LLC holds 19,944,809 shares of NVO stock, worth $1.62 Billion. This represents 1.06% of its overall portfolio holdings.
Number of Shares
19,944,809
Previous 20,195,957
1.24%
Holding current value
$1.62 Billion
Previous $2.4 Billion
28.66%
% of portfolio
1.06%
Previous 1.5%
Shares
24 transactions
Others Institutions Holding NVO
# of Institutions
1,908Shares Held
317MCall Options Held
5.49MPut Options Held
7.78M-
Morgan Stanley New York, NY14.4MShares$1.17 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.16 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.08 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$991 Million3.76% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD9.58MShares$777 Million0.13% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $183B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...